Hamilton Wealth’s Medtronic MDT Stock Holding History

Hamilton Wealth’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-77,278	Closed	-$6.24M	–	98
2022 Q3	$6.24M	Buy	77,278 +17,433	+29%	+$1.57M	2.64%	11
2022 Q2	$5.37M	Buy	+59,845	New	+$6.06M	2.1%	16

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hamilton Wealth's MDT Position: Q4 2022 in Review

Hamilton Wealth sold out of Medtronic (MDT) in Q4 2022, closing a stake of 77,278 shares — an estimated $6.24M sold.

Hamilton Wealth first reported a position in MDT in Q2 2022 and held it in 2 quarters. The position peaked at $6.24M in Q3 2022. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

Hamilton Wealth reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
Hamilton Wealth sold 77,278 Medtronic shares in Q4 2022, an estimated $6.24M.
Hamilton Wealth first reported a position in Medtronic in Q2 2022 and held it in 2 quarters.
Hamilton Wealth's Medtronic position peaked at $6.24M in Q3 2022.
1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Hamilton Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.